Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Sell
136,228
-11,149
-8% -$1.3M 0.23% 72
2026
Q1
$17.9M Sell
147,377
-44,434
-23% -$5.13M 0.19% 75
2025
Q4
$20.2M Sell
191,811
-1,727,191
-90% -$162M 0.19% 69
2025
Q3
$161M Buy
1,919,002
+37,932
+2% +$3.12M 1.58% 23
2025
Q2
$150M Sell
1,881,070
-358
-0% -$28.5K 1.95% 21
2025
Q1
$168M Sell
1,881,428
-913,772
-33% -$85.3M 2.33% 21
2024
Q4
$275M Buy
2,795,200
+20,542
+0.7% +$2.12M 3.72% 7
2024
Q3
$313M Buy
2,774,658
+385,225
+16% +$45.8M 4.28% 5
2024
Q2
$299M Buy
2,389,433
+243,599
+11% +$31.4M 4.53% 4
2024
Q1
$283M Buy
2,145,834
+4,593
+0.2% +$566K 4.24% 5
2023
Q4
$235M Buy
2,141,241
+55,268
+3% +$5.74M 3.85% 8
2023
Q3
$215M Sell
2,085,973
-25,669
-1% -$2.77M 3.86% 8
2023
Q2
$244M Sell
2,111,642
-26,146
-1% -$2.97M 4.97% 6
2023
Q1
$228M Buy
+2,137,788
New +$231M 5.08% 5

Other funds holding MRK

ABN AMRO Bank's MRK Position: Q2 2026 in Review

ABN AMRO Bank reduced its Merck (MRK) stake by 7.6% in Q2 2026, selling an estimated $1.3M and leaving 136,228 shares worth $17.5M. The position accounts for 0.23% of the portfolio, ranked #72.

ABN AMRO Bank first reported a position in MRK in Q1 2023 and has held it in 14 quarters since. The position peaked at $313M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • ABN AMRO Bank held 136,228 shares of Merck worth $17.5M as of Q2 2026.
  • ABN AMRO Bank sold 11,149 Merck shares in Q2 2026, an estimated $1.3M.
  • Merck made up 0.23% of ABN AMRO Bank's portfolio in Q2 2026, its #72 holding.
  • ABN AMRO Bank first reported a position in Merck in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Bank's Merck position peaked at $313M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.